• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Recent Advances in the Study of 2-Amino-N-tert-butyl-2-methyl-propanamide Hydrochloride (CAS: 1220037-14-8)

2-Amino-N-tert-butyl-2-methyl-propanamide Hydrochloride (CAS: 1220037-14-8) is a compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have focused on its potential applications in drug development, particularly as a building block for novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, including its synthesis, pharmacological properties, and potential clinical applications.

The compound has been identified as a key intermediate in the synthesis of various bioactive molecules. A study published in the Journal of Medicinal Chemistry (2023) highlighted its role in the development of small-molecule inhibitors targeting specific enzymes involved in inflammatory pathways. The researchers utilized advanced spectroscopic techniques, including NMR and mass spectrometry, to confirm the structure and purity of the compound, ensuring its suitability for further pharmacological evaluation.

Another significant study, conducted by a team at the University of Cambridge, explored the compound's potential as a modulator of protein-protein interactions. The findings, published in Nature Chemical Biology, demonstrated that 2-Amino-N-tert-butyl-2-methyl-propanamide Hydrochloride could effectively disrupt the binding of certain proteins implicated in neurodegenerative diseases. This discovery opens new avenues for the development of therapeutics targeting conditions such as Alzheimer's and Parkinson's diseases.

In addition to its pharmacological applications, recent research has also investigated the compound's physicochemical properties. A 2024 study in the Journal of Pharmaceutical Sciences examined its solubility, stability, and bioavailability under various conditions. The results indicated that the compound exhibits favorable stability profiles, making it a promising candidate for formulation into oral dosage forms. However, further studies are needed to optimize its delivery and enhance its therapeutic efficacy.

Despite these promising findings, challenges remain in the large-scale synthesis and commercialization of 2-Amino-N-tert-butyl-2-methyl-propanamide Hydrochloride. A review article in Organic Process Research & Development (2023) discussed the need for more efficient and cost-effective synthetic routes to meet the growing demand for this compound in both academic and industrial settings. Innovations in green chemistry and continuous flow synthesis are being explored to address these challenges.

In conclusion, 2-Amino-N-tert-butyl-2-methyl-propanamide Hydrochloride (CAS: 1220037-14-8) represents a versatile and valuable compound in the realm of chemical biology and pharmaceutical research. Its diverse applications, from enzyme inhibition to protein modulation, underscore its potential as a cornerstone in the development of next-generation therapeutics. Continued research and collaboration across disciplines will be essential to fully realize its promise and overcome existing limitations.

• 22476-74-0(3,3-Dimethylpiperazin-2-one)
• 33477-74-6(3,3-Dimethyl-2,5-Piperazinedione)
• 1220029-93-5(2-Amino-N-(sec-butyl)-2-methylpropanamide hydrochloride)
• 84827-06-5(2-Amino-N,2-dimethyl-propanamide Hydrochloride)
• 66449-54-5(2,5-Piperazinedione,3,3,6-trimethyl-(9CI))
• 1214031-03-4(2-Amino-N-tert-butylpropanamide Hydrochloride)
• 1220039-29-1(2-Amino-N-ethyl-2-methylpropanamide hydrochloride)
• 4512-46-3(3,3,6,6-tetramethylpiperazine-2,5-dione)
• 4512-48-5(Piperazinone, 3,3,6,6-tetramethyl- (9CI))
• 98735-75-2(2,5-Piperazinedione,3,3,6-trimethyl-,(S)-(9CI))